By Diabetes Research Institute
The development of the DRI BioHub [Video]
We’re excited to announce that the first patient in the Diabetes Research Institute clinical trial to test for the first time a novel transplant technique for insulin-producing cells was successfully completed recently!
This FDA-approved Phase I/II study builds upon decades of progress in islet transplantation and is an important first step toward the development of the DRI BioHub, a bioengineered mini-organ that will mimic the native pancreas to restore natural insulin production in people with type 1 diabetes. Hear from the patient in this latest edition of DRI tv.